Acadian Asset Management
ENZY

Acadian Asset Management’s Enzymotec Ltd ENZY Stock Holding History

Acadian Asset Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-17,913
Closed -$207K – 1757
2017
Q3 		$207K Sell
17,913
-178,393
-91% -$1.76M ﹤0.01% 911
2017
Q2 		$1.59M Sell
196,306
-40,878
-17% -$341K 0.01% 616
2017
Q1 		$2.09M Buy
237,184
+7,322
+3% +$62K 0.01% 604
2016
Q4 		$1.51M Buy
229,862
+1,558
+0.7% +$10.3K 0.01% 641
2016
Q3 		$1.59M Sell
228,304
-20,013
-8% -$160K 0.01% 601
2016
Q2 		$2.08M Buy
248,317
+79,579
+47% +$659K 0.01% 516
2016
Q1 		$1.52M Buy
168,738
+50,666
+43% +$441K 0.01% 584
2015
Q4 		$1.16M Buy
118,072
+66,702
+130% +$632K 0.01% 664
2015
Q3 		$464K Buy
51,370
+44,497
+647% +$397K ﹤0.01% 786
2015
Q2 		$57K Hold
6,873
– – ﹤0.01% 1058
2015
Q1 		$49K Hold
6,873
– – ﹤0.01% 1083
2014
Q4 		$53K Hold
6,873
– – ﹤0.01% 1046
2014
Q3 		$46K Sell
6,873
-7,840
-53% -$84.6K ﹤0.01% 876
2014
Q2 		$200K Sell
14,713
-50,862
-78% -$854K ﹤0.01% 791
2014
Q1 		$1.44M Buy
65,575
+40,303
+159% +$1.07M 0.01% 531
2013
Q4 		$682K Buy
+25,272
New +$601K ﹤0.01% 633

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
GH
GAM Holding Zurich, Switzerland $1.57B AUM 25.73% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
CRA
Circle Road Advisors New York $27.7M AUM 35.85% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management's ENZY Position: Q4 2017 in Review

Acadian Asset Management sold out of Enzymotec Ltd (ENZY) in Q4 2017, closing a stake of 17,913 shares — an estimated $207K sold.

Acadian Asset Management first reported a position in ENZY in Q4 2013 and held it in 16 quarters. The position peaked at $2.09M in Q1 2017. 37 funds tracked by Wall St. Rank hold ENZY as of Q4 2017.

  • Acadian Asset Management reported no remaining Enzymotec Ltd position as of Q4 2017 after selling out during the quarter.
  • Acadian Asset Management sold 17,913 Enzymotec Ltd shares in Q4 2017, an estimated $207K.
  • Acadian Asset Management first reported a position in Enzymotec Ltd in Q4 2013 and held it in 16 quarters.
  • Acadian Asset Management's Enzymotec Ltd position peaked at $2.09M in Q1 2017.
  • 37 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q4 2017.

Based on Acadian Asset Management's 13F filing for Q4 2017, filed 18 Jan 2018.